Skip to content

V5M

by Acuson Corp.

510(k) K942296

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK942296 Date2 Mar 1995ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
ITX
Device Class
Class II
Regulation
21 CFR Part 892.1570
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The V5M is a diagnostic ultrasound imaging system, classified under the product code ITX for radiology devices. It is designed to produce real-time visual images of internal body structures using high-frequency sound waves, aiding in the diagnosis and monitoring of various medical conditions.

The V5M is supplied as a reusable medical device and is intended for use in clinical settings such as hospitals and diagnostic imaging centers. It is not specified as MRI-safe or sterile upon packaging, and its regulatory clearance was granted under the FDA’s 510(k) pathway as substantially equivalent to a predicate device. The device was cleared in 1995 under K-number K942296.

Other devices from Acuson Corp.

See all devices from Acuson Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the V5M ultrasound system designed for single-use or repeated use in clinical settings, and how does this affect its maintenance requirements?

    The V5M is explicitly described as a reusable medical device, intended for use in hospitals and diagnostic imaging centers. Since it is not single-use, it requires regular cleaning, disinfection, and maintenance as outlined in the manufacturer’s instructions to ensure proper function and patient safety. Reusable devices like this typically undergo scheduled servicing to maintain performance and compliance with clinical standards.

  • What type of regulatory clearance does the V5M hold, and how does this relate to its intended use in radiology?

    The V5M received FDA 510(k) clearance in 1995 under the product code ITX, which categorizes it as a radiology device. This clearance was granted under the substantially equivalent determination, meaning it was deemed comparable to a previously approved predicate device. The Radiology (RA) Advisory Committee reviewed it, confirming its classification as a diagnostic ultrasound system for imaging internal body structures in clinical settings.

  • Does the V5M come pre-sterilized, or is it intended to be sterilized before first use in a clinical environment?

    The V5M is not specified as sterile upon packaging, which means it is not pre-sterilized for immediate clinical use. Since it is a reusable device, it must undergo proper cleaning, disinfection, and sterilization procedures as required by clinical protocols before each use to ensure patient safety and device efficacy.

  • What year was the V5M originally cleared by the FDA, and what does this mean for its ongoing compliance and updates?

    The V5M was cleared by the FDA in 1995 under K-number K942296, meaning it was originally evaluated for substantial equivalence to a predicate device at that time. While this indicates initial compliance, manufacturers of cleared devices must still adhere to ongoing regulatory requirements, including post-market surveillance and any necessary updates or modifications, to maintain compliance with current FDA standards.